ScreenerHero
NN6NanoRepro AG
XETRA · DE · Healthcare · Diagnostics & Research · nanorepro.com
1.910EUR+1.33%Mkt Cap: 26.19M $P/E: —

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the are…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group AG
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap26.19M $
Enterprise Value17.41M $
Revenue (TTM)4.71M $
Gross Profit3.20M $
Net Income (TTM)-2.22M $
Revenue/Share0.3739 USD
Last Price1.910 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees22
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISINDE0006577109
Valuation
P/E (Trailing)—
P/E (Forward)47.75
PEG—
EV/EBITDA-7.83
EV/Revenue3.69
P/S5.56
P/B0.67
EPS (TTM)-0.14
EPS (Forward)0.04
52W Range
1.31055% of range2.400
52W High2.400 EUR
52W Low1.310 EUR
Profitability
Gross Margin63.38%
Oper. Margin-60.04%
EBITDA Margin-47.20%
Profit Margin-44.02%
ROE-5.36%
ROA-5.24%
Growth
Revenue Growth-29.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF10.72M $
CapEx (TTM)437.61K $
FCF Margin—
FCF Yield—
Net Debt-8.44M $
Net Debt/EBITDA3.79
Balance Sheet
Debt/Equity—
Current Ratio36.72
Quick Ratio33.08
Book Value/Sh2.866 EUR
Cash/Share0.6150 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 16, 2023
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.450 EUR
Upside (mean)+133.0%
Target Range4.400 EUR – 4.500 EUR
€4.400+133.0% to mean€4.500
# Analysts2
Ownership
Shares Out.12.61M
Float—
Insiders2.00%
Institutions8.94%
Technical
SMA 502.040 (-6.4%)
SMA 2001.664 (+14.8%)
Beta0.46
S&P 52W Chg18.16%
Avg Vol (30d)12.35K
Avg Vol (10d)10.50K
Technical Indicators
RSI (14)41.3
MACD-0.0352
MACD Signal-0.0193
MACD Hist.-0.0159
BB Upper2.166 EUR
BB Middle2.001 EUR
BB Lower1.836 EUR
BB Width16.51%
ATR (14)0.1101 EUR
Vol Ratio (20d)0.75x